Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
06/2000
06/29/2000WO2000037487A1 αvβ6 INTEGRIN INHIBITORS
06/29/2000WO2000037474A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use
06/29/2000WO2000037472A2 Substituted pirroloindoles
06/29/2000WO2000037470A1 Antihistaminic spiro compounds
06/29/2000WO2000037462A1 Non-peptide nk1 receptors antagonists
06/29/2000WO2000037436A1 Sulfonamide hydroxamates
06/29/2000WO2000037429A2 INHIBITORS OF α4β1 MEDIATED CELL ADHESION
06/29/2000WO2000037422A2 Ion channel modulating agents
06/29/2000WO2000037358A1 NOVEL sPLA2 INHIBITORS
06/29/2000WO2000037107A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia
06/29/2000WO2000037088A1 Use of etherlysophospholipids as antiinflammatory agents
06/29/2000WO2000037076A1 Combinations of farnesyl transferase inhibitors and irinotecan or camptothecin for treating cancer
06/29/2000WO2000037067A2 Sensitizing agents for the treatment of skin lesions
06/29/2000WO2000037040A1 Skin care compositions containing cis-9, trans-11 linoleic acid
06/29/2000WO2000037037A2 Composition for treatment of burns
06/29/2000WO2000037035A1 Deodorizing cosmetic agents
06/29/2000WO2000037027A1 Oil-in-water emulsion comprising a micronised biologically active agent and an appropriate emulsifier system
06/29/2000WO2000037025A2 Antibodies to truncated vegf-d and uses thereof
06/29/2000WO2000012726A3 Rationally designed heparinases derived from heparinase i and ii
06/29/2000WO2000012497A3 Quinazoline derivatives as medicaments
06/29/2000WO2000012175A3 Methimazole derivatives and tautomeric cyclic thiones to treat autoimmune diseases
06/29/2000WO2000012113A3 Method of modulating memory effector t-cells using a cd2-binding agent, and compositions
06/29/2000WO1999064034A9 β2-ADRENERGIC RECEPTOR AGONISTS
06/29/2000DE19860719A1 Neue Testosteronderivate und ihre Verwendung zur Langzeittherapie von Androgen-abhängigen Erkrankungen New testosterone derivatives and their use for long-term therapy of androgen-dependent diseases
06/29/2000DE19859611A1 Spreadable fibrin adhesive granulate for e.g. healing surgical wounds, contains thrombin, factor XIII, fibrinogen and calcium salt
06/29/2000DE19858812A1 Desodorierende kosmetische Mittel Deodorizing cosmetic products
06/29/2000CA2357413A1 Sensitizing agents for the treatment of skin lesions
06/29/2000CA2356736A1 Use of etherlysophospholipids as antiinflammatory agents
06/29/2000CA2356426A1 Method of using a cyclooxygenase-2 inhibitor and a matrix metalloproteinase inhibitor as a combination therapy in the treatment of neoplasia
06/29/2000CA2356366A1 Oil-in-water emulsion comprising a micronised biologically active agent and an appropriate emulsifier system
06/29/2000CA2356174A1 Kidney disease detection and treatment
06/29/2000CA2356162A1 Substituted tricyclics
06/29/2000CA2356159A1 Novel spla2 inhibitors
06/29/2000CA2355902A1 Sulfonamide hydroxamates
06/29/2000CA2355896A1 Antibodies to truncated vegf-d and uses thereof
06/29/2000CA2355874A1 .alpha.v.beta.6 integrin inhibitors
06/29/2000CA2355137A1 Non-peptide nk1 receptors antagonists
06/29/2000CA2355074A1 Lymphocytic membrane proteins
06/29/2000CA2353907A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use
06/29/2000CA2333626A1 Method for prevention and treatment of cancer and other cell proliferative diseases with ultrasonics
06/29/2000CA2293177A1 Nanoemulsion based on ethoxylate fatty ethers or ethoxylate fatty esters, and its utilizations in cosmetics, dermatology and/or ophthalmology
06/28/2000EP1013266A1 Use of N-acyl aminoacids as texturing agents
06/28/2000EP1013258A2 Amphipatic lipid dispersion
06/28/2000EP1012308A1 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors
06/28/2000EP1012305A1 Component of bromelain
06/28/2000EP1012278A1 Murine and human cerberus-like proteins and compositions comprising them
06/28/2000EP1012273A2 Secreted proteins and polynucleotides encoding them
06/28/2000EP1012266A1 Galectin 8, 9, 10 and 10sv
06/28/2000EP1012262A1 Human frezzled-like protein
06/28/2000EP1012247A1 Short peptides which selectively modulate intracellular signalling
06/28/2000EP1012242A1 Human sigma receptor
06/28/2000EP1012187A2 Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response
06/28/2000EP1011734A1 Gene therapy vehicle comprising dermal sheath tissue
06/28/2000EP1011725A1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
06/28/2000EP1011709A1 Inhibition of apoptotis using prosaposin receptor agonists
06/28/2000EP1011663A1 BETA-LACTAM INHIBITORS OF CoA-IT
06/28/2000EP1011649A2 Use of endipalene in the treatment of psoriasis
06/28/2000EP1011647A1 Spray formulations of antihyperalgesic opiates and method of treating topical hyperalgesic conditions and pruritus therewith
06/28/2000EP1011610A1 Skin care compositions and use
06/28/2000EP1011607A2 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
06/28/2000EP0706394A4 Method and composition for topical treatment of damaged tissue using histamine phosphate as active ingredient
06/28/2000EP0639224B1 Lectin domain variants of selectin
06/28/2000CN1258293A Substd. 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and method of reducing TNF 'alpha' levels
06/28/2000CN1258280A Cyanoamidines as cell proliferation inhibitors
06/28/2000CN1258279A Cyanoguanidines as cell proliferation inhibitors
06/28/2000CN1258278A Cyanoguanidines as cell proliferation inhibitors
06/28/2000CN1258277A Cyanoguanidines as cell proliferation inhibitors
06/28/2000CN1258276A Cyanoguanidines as cell proliferation inhibitors
06/28/2000CN1258219A Benzocycloheptathiophene compounds
06/28/2000CN1257708A Medicine for treating leukoderma
06/28/2000CN1257700A Sun-shielding cream containing natural snow lotus
06/28/2000CN1053904C N-pyridyl carboxamides and derivs. processes for their preparation and pharmaceutical compositions contg. them
06/28/2000CN1053824C Exterior-use traditional Chinese medicine ointment and its preparing method
06/28/2000CN1053821C Burn medicine and preparation method thereof
06/28/2000CN1053820C Medicine for treatment of burn and scald, and its preparing method
06/28/2000CN1053819C Ointment for treatment of itching disease
06/28/2000CN1053818C 溃疡散 Ulcers scattered
06/27/2000US6080878 Method of preparing 16-dehydro vitamin D compounds
06/27/2000US6080841 Human induced tumor protein
06/27/2000US6080774 Substituted biphenylsulfonamide endothelin antagonists
06/27/2000US6080769 Imidazolidin-4-one derivatives useful as anticancer agents
06/27/2000US6080766 Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation
06/27/2000US6080754 For treatment and prophylaxis of estrogen related syndromes and disorders
06/27/2000US6080546 Antisense modulation of MEKK5 expression
06/27/2000US6080416 A hydroalcohol mixture of stearoxytrimethylsilane, cyclomethicone, cetyl lactate and a c1-15 alkyl lactate and ethyh, isopropyl and/or propyl alcohol and/or water; nontacky; moisturizing; protective coatings; skins
06/27/2000US6080388 Cosmetic and dermatological sunscreen formulations containing triazine derivatives and alkane carboxylic acids
06/22/2000WO2000036105A1 Prostacyclin-stimulating factor-2
06/22/2000WO2000035939A2 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000WO2000035936A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000WO2000035915A1 Piperazine derivatives
06/22/2000WO2000035848A1 Aldose reductase inhibitors and pharmaceutical compositions
06/22/2000WO2000035452A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000WO2000035442A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
06/22/2000WO2000035434A2 Compositions and methods for the treatment of anorectal disorders
06/22/2000WO2000035428A2 Tricyclic nitrogen heterocycles as pde iv inhibitors
06/22/2000WO2000004954A3 Novel urokinase inhibitors
06/22/2000WO2000004870A3 Composition for enhancing epidermal lipid production
06/22/2000CA2355890A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
06/22/2000CA2355363A1 Prostacyclin-stimulating factor-2
06/22/2000CA2355211A1 Aldose reductase inhibitors and pharmaceutical compositions
1 ... 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 ... 1065